Percutaneous Obliteration of Urinary Leakage after Partial Nephrectomy Using N-Butyl-Cyanoacrylate Obliteration of the Urinoma with or without Coil Embolization of the Fistula Tract

J Vasc Interv Radiol. 2019 Dec;30(12):2002-2008. doi: 10.1016/j.jvir.2019.05.019. Epub 2019 Aug 13.

Abstract

Purpose: To retrospectively evaluate the safety and efficacy of the percutaneous obliteration of urinary leakage after partial nephrectomy (PN) using coils and N-butyl-cyanoacrylate (NBCA).

Materials and methods: Data of 10 consecutive patients who underwent percutaneous obliteration of urinary leakage after PN using coil and NBCA between February 2016 and May 2018 were retrospectively reviewed. A urinary fistulography was performed via the drainage catheter. If the fistulous tract was clearly visualized, super-selective embolization of the fistulous tract with coils and urinoma cavity sealing with NBCA was performed. In cases where the fistulous tract could not be clearly visualized, only urinoma cavity sealing was performed. Outcomes and complications were assessed by reviewing medical records and computed tomography (CT).

Results: In 7 (70%) patients who showed obvious urinary fistulous tract, coil embolization of the urinary fistulous tract, followed by sealing of the urinoma cavity with NBCA, was performed. Obliteration of the urinoma without coil embolization of the fistula tract was performed in 3 patients (30%) in whom a distinct fistulous tract could not be visualized. The median number of treatment sessions required to achieve clinical success was 1 (range, 1-5). Four patients underwent multiple repeated procedure with successful results. All patients showed gradual decrease in size or complete disappearance of urinoma on follow-up CT without evidence of urinary leakage during the follow-up period (mean, 44.6 weeks; range, 11-117 weeks). There were no procedure-related complications.

Conclusions: Percutaneous obliteration of urinary leakage after PN using coils and NBCA is safe and effective.

MeSH terms

  • Adult
  • Aged
  • Embolization, Therapeutic / adverse effects
  • Embolization, Therapeutic / instrumentation*
  • Enbucrilate / administration & dosage*
  • Enbucrilate / adverse effects
  • Female
  • Humans
  • Kidney Neoplasms / pathology
  • Kidney Neoplasms / surgery*
  • Male
  • Middle Aged
  • Nephrectomy / adverse effects*
  • Retrospective Studies
  • Risk Factors
  • Treatment Outcome
  • Urinary Fistula / diagnostic imaging
  • Urinary Fistula / etiology
  • Urinary Fistula / therapy*
  • Urinary Incontinence / diagnostic imaging
  • Urinary Incontinence / etiology
  • Urinary Incontinence / therapy*
  • Urinoma / diagnostic imaging
  • Urinoma / etiology
  • Urinoma / therapy*

Substances

  • Enbucrilate